Human papillomavirus vaccination coverage among young women in the three sub-Saharan African countries using Demographic and Health Surveys data

References

• Bonjour M, Charvat H, Franco EL, Piñeros M, Clifford GM, Bray F, Baussano I. Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: a birth cohort analysis. The Lancet Public Health. 2021;6(7):510–6. doi:10.1016/S2468-2667(21)00046-3.
   PubMed Web of Science ®Google Scholar
• Vu M, Yu J, Awolude OA, Chuang L. Cervical cancer worldwide. Curr Probl Cancer. 2018;42(5):457–65. doi:10.1016/j.currproblcancer.2018.06.003.
   PubMed Web of Science ®Google Scholar
• Abbas KM, van Zandvoort K, Brisson M, Jit M. Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study. Lancet Glob Health. 2020;8(4):536–44. doi:10.1016/S2214-109X(20)30022-X.
   Web of Science ®Google Scholar
• Huang Y, Wu X, Lin Y, Li W, Liu J, Song B. Multiple sexual partners and vaginal microecological disorder are associated with HPV infection and cervical carcinoma development. Oncol Lett. 2020;20(2):1915–21. doi:10.3892/ol.2020.11738.
   PubMed Web of Science ®Google Scholar
• Organization WH. Human papillomavirus vaccines: WHO position paper, May 2017–Recommendations. Vaccine. 2017;35(43):5753–5.
   PubMed Web of Science ®Google Scholar
• Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol. 2020;40(5):602–8. doi:10.1080/01443615.2019.1634030.
   PubMedGoogle Scholar
• Ma L, Lei J, Ma L, Cong X, Wang N, Yang H, Liu Q, Yu Y, Cao Y. Characteristics of women infected with human papillomavirus in a tertiary hospital in Beijing China, 2014–2018. BMC Infect Dis. 2019;19(1):1–8. doi:10.1186/s12879-019-4313-8.
   PubMedGoogle Scholar
• Berman TA, Schiller JT. Human papillomavirus in cervical cancer and oropharyngeal cancer: one cause, two diseases. Cancer. 2017;123(12):2219–29. doi:10.1002/cncr.30588.
   PubMed Web of Science ®Google Scholar
• Drolet M, Laprise J-F, Martin D, Jit M, Bénard É, Gingras G, Boily M-C, Alary M, Baussano I, Hutubessy R, et al. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis. Lancet Infect Dis. 2021;21(11):1598–610. doi:10.1016/S1473-3099(20)30860-4.
   PubMed Web of Science ®Google Scholar
• Schwarz TF, Huang L-M, Valencia A, Panzer F, Chiu C-H, Decreux A, Poncelet S, Karkada N, Folschweiller N, Lin L, et al. A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years. Hum Vaccines Immunother. 2019;15(7–8):1970–9. doi:10.1080/21645515.2019.1625644.
   PubMed Web of Science ®Google Scholar
• Mavundza EJ, Jaca A, Ndwandwe D, Cooper S. Facebook users’ attitudes towards human papillomavirus vaccination in South Africa. 2023.
   Google Scholar
• Whitworth HS, Gallagher KE, Howard N, Mounier-Jack S, Mbwanji G, Kreimer AR, Basu P, Kelly H, Drolet M, Brisson M, et al. Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: a systematic review of evidence from clinical trials. Vaccine. 2020;38(6):1302–14. doi:10.1016/j.vaccine.2019.12.017.
   PubMed Web of Science ®Google Scholar
• White MD. Pros, cons, and ethics of HPV vaccine in teens-Why such controversy? Transl Androl Urol. 2014;3(4):429–34. doi:10.3978/j.issn.2223-4683.2014.11.02.
   PubMedGoogle Scholar
• Brown B, Folayan M. Barriers to uptake of human papilloma virus vaccine in Nigeria: a population in need. Niger Med J. 2015;56(4):301. doi:10.4103/0300-1652.165033.
   PubMedGoogle Scholar
• Leidner AJ, Chesson HW, Talih M. HPV vaccine status and sexual behavior among young sexually-active women in the US: evidence from the national health and nutrition examination survey, 2007–2014. Health Econ Policy Law. 2020;15(4):477–95. doi:10.1017/S1744133119000136.
   PubMed Web of Science ®Google Scholar
• Mekonnen AG, Mittiku YM, Linde DS. Early-onset of sexual activity as a potential risk of cervical cancer in Africa: a review of literature. PLOS Glob Public Health. 2023;3(3):e0000941. doi:10.1371/journal.pgph.0000941.
   PubMedGoogle Scholar
• Tadesse SK. Socio-economic and cultural vulnerabilities to cervical cancer and challenges faced by patients attending care at Tikur Anbessa hospital: a cross sectional and qualitative study. BMC Women’s Health. 2015;15(1):75. doi:10.1186/s12905-015-0231-0.
   PubMedGoogle Scholar
• Zegeye AF, Negash WD, Kassie AT, Wassie LA, Tamir TT, Gebrekidan K. Home delivery among women who had optimal ANC follow-up in sub-Saharan Africa: a multilevel analysis. PLOS ONE. 2023;18(11):e0295289. doi:10.1371/journal.pone.0295289.
   PubMed Web of Science ®Google Scholar
• Spayne J, Hesketh T. Estimate of global human papillomavirus vaccination coverage: analysis of country-level indicators. BMJ Open. 2021;11(9):e052016. doi:10.1136/bmjopen-2021-052016.
   PubMed Web of Science ®Google Scholar
• Bruni L, Diaz M, Barrionuevo-Rosas L, Herrero R, Bray F, Bosch FX, de Sanjosé S, Castellsagué X. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health. 2016;4(7):453–63. doi:10.1016/S2214-109X(16)30099-7.
   PubMed Web of Science ®Google Scholar
• Thomas TL, Strickland OL, Higgins M. Mothers, fathers, sons, and human papillomavirus immunization practices. Fam Community Health. 2017;40(3):278–87. doi:10.1097/FCH.0000000000000104.
   PubMed Web of Science ®Google Scholar
• Nolan J, Renderos TB, Hynson J, Dai X, Chow W, Christie A, et al. Barriers to cervical cancer screening and follow‐up care among black women in Massachusetts. J Obstetric, Gynecologic & Neonatal Nurs. 2014;43(5):580–8. doi:10.1111/1552-6909.12488.
   PubMed Web of Science ®Google Scholar
• Ferrer HB, Trotter C, Hickman M, Audrey S. Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis. BMC Public Health. 2014;14(1):700. doi:10.1186/1471-2458-14-700.
   PubMedGoogle Scholar
• White MD. Pros, cons, and ethics of HPV vaccine in teens—Why such controversy? Transl Androl Urol. 2014;3(4):429–34. doi:10.3978/j.issn.2223-4683.2014.11.02.
   PubMedGoogle Scholar
• Cunningham MS, Davison C, Aronson KJ. HPV vaccine acceptability in Africa: a systematic review. Prev Med. 2014;69:274–9. doi:10.1016/j.ypmed.2014.08.035.
   PubMed Web of Science ®Google Scholar
• Llavona-Ortiz JY, Spanos KE. Associations between human papillomavirus vaccine decisions and exposure to vaccine information in social media. Cancer Control. 2022;29:10732748221138404. doi:10.1177/10732748221138404.
   Web of Science ®Google Scholar
• Dib F, Mayaud P, Longfier L, Chauvin P, Launay O. Effect of internet use for searching information on vaccination on the uptake of human papillomavirus vaccine in France: a path-analysis approach. Prev Med. 2021;149:106615. doi:10.1016/j.ypmed.2021.106615.
   PubMed Web of Science ®Google Scholar
• Ortiz RR, Smith A, Coyne-Beasley T. A systematic literature review to examine the potential for social media to impact HPV vaccine uptake and awareness, knowledge, and attitudes about HPV and HPV vaccination. Hum Vaccines Immunother. 2019;15(7–8):1465–75. doi:10.1080/21645515.2019.1581543.
   PubMed Web of Science ®Google Scholar
• Wubu A, Balta B, Cherie A, Bizuwork K. Perception about human papillomavirus vaccination among middle adolescent school girls in Addis Ababa, Ethiopia 2023: qualitative study. BMC Women’s Health. 2023;23(1):520. doi:10.1186/s12905-023-02660-1.
   PubMed Web of Science ®Google Scholar
• Galvin AM, Garg A, Moore JD, Litt DM, Thompson EL. Quality over quantity: human papillomavirus vaccine information on social media and associations with adult and child vaccination. Hum Vaccines Immunother. 2021;17(10):3587–94. doi:10.1080/21645515.2021.1932219.
   PubMed Web of Science ®Google Scholar
• Pan S, Zhang D, Zhang J. Caught in the crossfire: how contradictory information and norms on social media influence young women’s intentions to receive HPV vaccination in the United States and China. Front Psychol. 2020;11:548365. doi:10.3389/fpsyg.2020.548365.
   PubMed Web of Science ®Google Scholar
• Zewdie A, Kasahun AW, Adane HA, Mose A. Willingness to vaccinate their daughters against human papillomavirus among parents of Ethiopian adolescent girls: a systematic review and meta-analysis. J Pharm Policy Pract. 2023;16(1):126. doi:10.1186/s40545-023-00639-9.
   PubMed Web of Science ®Google Scholar
• Frianto D, Setiawan D, Diantini A, Suwantika AA. Economic evaluations of HPV vaccination in targeted regions of low- and middle-income countries: a systematic review of modelling studies. Int J Womens Health. 2022;14:1315–22. doi:10.2147/IJWH.S367953.
   PubMed Web of Science ®Google Scholar
• Kim JJ, Goldie SJ. Health and economic implications of HPV vaccination in the United States. N Engl J Med. 2008;359(8):821–32. doi:10.1056/NEJMsa0707052.
   PubMed Web of Science ®Google Scholar